当代治疗的霍奇金淋巴瘤患者生育潜力与匹配对照人群一致
基于瑞典登记数据,1992至2009年确诊的449名18至40岁霍奇金淋巴瘤女性患者与2210名年龄和日历年份匹配的普通人群对照比较,无复发患者中22%在随访期间生育,2004至2009年确诊患者的累积生育概率与对照相似,诊断3年后生育率无差异。
要点
- 无复发的霍奇金淋巴瘤女性患者中22%在随访期间生育。
- 首胎生育率从1992至1997年的40.2/1000人年升至2004至2009年的69.7/1000人年。
- 诊断3年后,无论分期或治疗,患者与对照的生育率无差异。
核心结论
- 女性霍奇金淋巴瘤幸存者的生育潜力随时间改善,当代治疗患者在无复发情况下诊断3年后的生育率与普通人群相似,无论分期和治疗如何。
研究设计与样本
- 使用瑞典登记数据,识别1992至2009年确诊的449名18至40岁霍奇金淋巴瘤女性患者,诊断后9个月处于缓解期,按年龄和日历年份匹配2210名普通人群对照。
- 计算诊断后首次生育率,使用Cox回归估计不同随访期的风险比(HR)及95%CI,并在考虑死亡或复发竞争风险下计算首次生育的累积概率。
主要发现
- 无复发的霍奇金淋巴瘤患者中22%在随访期间生育。
- 首胎生育率从1992至1997年的40.2/1000人年上升至2004至2009年的69.7/1000人年,对照人群生育率保持稳定在70.1/1000人年。
- 2004至2009年确诊患者的累积生育概率与对照相似。
- 诊断3年或更长时间后,患者与对照的生育率无差异,无论分期或治疗。
- 接受6至8疗程博来霉素、依托泊苷、多柔比星、环磷酰胺、长春新碱、丙卡巴肼和泼尼松方案的患者在诊断后前3年生育率低于对照(HR,0.23;95%CI,0.06至0.94);接受6至8疗程化疗和放疗的患者同样低于对照(HR,0.21;95%CI,0.07至0.65)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose With excellent cure rates for young patients with Hodgkin lymphoma (HL), there is an increasing number of female survivors of HL interested in becoming pregnant. Here, we report childbearing among contemporarily treated HL survivors in comparison with the general population. Material and Methods Using Swedish registers, 449 women (ages 18 to 40 years) diagnosed with HL between 1992 and 2009 and in remission 9 months after diagnosis were identified. Patients were age- and calendar-year-matched to 2,210 population comparators. Rates of first postdiagnosis childbirth were calculated. Hazard ratios (HRs) with 95% CIs were estimated for different follow-up periods using Cox regression. Cumulative probabilities of first childbirth were calculated in the presence of the competing risk of death or relapse. Results Twenty-two percent of relapse-free patients with HL had a child during follow-up, and first childbirth rates increased over time, from 40.2 per 1,000 person-years (1992 to 1997) to 69.7 per 1,000 person-years (2004 to 2009). For comparators, childbirth rates remained stable (70.1 per 1,000 person-years). Patients diagnosed between 2004 and 2009 had a cumulative probability of childbirth similar to comparators. Three years or more after diagnosis, no differences in childbirth rates were observed between patients and comparators, regardless of stage or treatment. Patients who received six to eight courses of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone had a lower childbirth rate than comparators during the first 3 years (HR, 0.23; 95% CI, 0.06 to 0.94), as did patients who received six to eight courses of chemotherapy and radiotherapy (HR, 0.21; 95% CI, 0.07 to 0.65). Conclusion Childbearing potential among female survivors of HL has improved over time, and childbirth rates 3 years after diagnosis in contemporarily treated patients are, in the absence of relapse, similar to those in the general population, regardless of stage and treatment.
引用
- Weibull CE, Johansson ALV, Eloranta S, et al. Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators. J Clin Oncol. 2018. PMID: 30044694. doi:10.1200/JCO.2018.78.3514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。